149 related articles for article (PubMed ID: 1544842)
1. Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugs.
Fielden EM; Adams GE; Cole S; Naylor MA; O'Neill P; Stephens MA; Stratford IJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):707-11. PubMed ID: 1544842
[TBL] [Abstract][Full Text] [Related]
2. Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers.
Naylor MA; Stephens MA; Stratford IJ; Keohane A; O'Neill P; Threadgill MD; Webb P; Fielden EM; Adams GE
Anticancer Drug Des; 1991 Jul; 6(3):151-67. PubMed ID: 1872946
[TBL] [Abstract][Full Text] [Related]
3. Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA 100 and TA98.
Chin JB; Sheinin DM; Rauth AM
Mutat Res; 1978 Sep; 58(1):1-10. PubMed ID: 362190
[TBL] [Abstract][Full Text] [Related]
4. Bioreductive therapies: an overview of drugs and their mechanisms of action.
Rauth AM; Melo T; Misra V
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):755-62. PubMed ID: 9845091
[TBL] [Abstract][Full Text] [Related]
5. The use of nitroaromatic compounds as hypoxic cell radiosensitizers.
Wardman P
Curr Top Radiat Res Q; 1977 Aug; 11(4):347-98. PubMed ID: 330116
[No Abstract] [Full Text] [Related]
6. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
7. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents.
Jenkins TC; Stratford IJ; Stephens MA
Anticancer Drug Des; 1989 Aug; 4(2):145-60. PubMed ID: 2803463
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of dual function nitrofurans in rodent and human tumor cells.
Siemann DW
Int J Radiat Oncol Biol Phys; 1992; 22(4):697-700. PubMed ID: 1544840
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
[TBL] [Abstract][Full Text] [Related]
10. Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976.
Adams GE; Flockhart IR; Smithen CE; Stratford IJ; Wardman P; Watts ME
Radiat Res; 2012 Aug; 178(2):AV183-9. PubMed ID: 22870968
[No Abstract] [Full Text] [Related]
11. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
Roizin-Towle L; Pirro JP; Hall EJ
Radiat Res; 1990 Oct; 124(1 Suppl):S50-5. PubMed ID: 2236511
[TBL] [Abstract][Full Text] [Related]
12. Theoretical approach for radiosensitizers. Correlation between calculated electroaffinity and sensitization factors of nitro-compounds.
Smeyers YG; De Bueren A; Alcala R; Alvarez MV
Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Jun; 39(6):649-53. PubMed ID: 6972930
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
Tercel M; Lee AE; Hogg A; Anderson RF; Lee HH; Siim BG; Denny WA; Wilson WR
J Med Chem; 2001 Oct; 44(21):3511-22. PubMed ID: 11585455
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice.
Lee AE; Wilson WR
Toxicol Appl Pharmacol; 2000 Feb; 163(1):50-9. PubMed ID: 10662604
[TBL] [Abstract][Full Text] [Related]
15. Some examples of anomalous radiosensitizing behaviour of electron-affinic compounds in vitro.
Watts ME; Jacobs RS
Br J Cancer Suppl; 1978 Jun; 3():80-3. PubMed ID: 277262
[TBL] [Abstract][Full Text] [Related]
16. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles.
Asquith JC; Watts ME; Patel K; Smithen CE; Adams GE
Radiat Res; 1974 Oct; 60(1):108-18. PubMed ID: 10881704
[No Abstract] [Full Text] [Related]
17. Nitroimidazoles as anti-tumor agents.
Liu K; Zhu HL
Anticancer Agents Med Chem; 2011 Sep; 11(7):687-91. PubMed ID: 21521156
[TBL] [Abstract][Full Text] [Related]
18. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
[TBL] [Abstract][Full Text] [Related]
19. Failla Memorial Lecture. Redox, radiation, and reductive bioactivation.
Adams GE
Radiat Res; 1992 Nov; 132(2):129-39. PubMed ID: 1438693
[TBL] [Abstract][Full Text] [Related]
20. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Papadopoulou MV; Bloomer WD
Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
